Involvement of tyrosine kinase pathway in acute hypoxic vasoconstriction in sheep isolated pulmonary vein

Vascular Pharmacology

Volumn 40, Issue 3, 2003, Pages 175-181

  Uzun, Özge ^a   Demiryürek, A Tuncay ^b,c  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Genistein; Hypoxia; Sodium orthovanadate; Tyrphostin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CARBON DIOXIDE; GENISTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TYRPHOSTIN; VANADATE SODIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SELECTIVITY; ENZYME ACTIVATION; HYPOXIA; LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; SHEEP;

EID: 0041333125     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00051-X     Document Type: Article

References (37)

1. Abebe W., Agrawal D.K. The role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J. Cardiovasc. Pharmacol. 26:1995;153-159.
2. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanable S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
3. Burkhoff D., Tyberg J. Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. Am. J. Physiol. 265:1993;H1819-H1828.
4. Demiryürek A.T., Wadsworth R.M., Kane K.A. Effects of hypoxia on isolated intrapulmonary arteries from the sheep. Pulm. Pharmacol. 4:1991;158-164.
5. Demiryürek A.T., Wadsworth R.M., Kane K.A., Peacock A.J. The role of endothelium in hypoxic constriction of human pulmonary artery rings. Am. Rev. Respir. Dis. 147:1993;283-290.
6. Di Salvo J., Semenchuk L.A., Lauer J. Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch. Biochem. Biophys. 304:1993;386-391.
7. Di Salvo J., Steusloff A., Semenchuk L., Satoh S., Kolquist K., Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190:1993;968-974.
8. Dumas J.P., Bardou M., Goirand F., Dumas M. Hypoxic pulmonary vasoconstriction. Gen. Pharmacol. 3:1999;289-297.
9. Gazit A., Yaish P., Gilon C., Levitzki A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:1989;2344-2352.
10. Hakim T.S., Michel R.P., Chang H.K. Partitioning of pulmonary vascular resistance by arterial and venous occlusion method. J. Appl. Physiol. 52:1982;710-715.
11. Hasebe N., Onodera S., Yamashita H., Kawamura Y., Haneda T., Tobise K. Site of hypoxic pulmonary vasoconstriction in pulsatile perfused canine lung lobes. Jpn. Circ. J. 56:1992;837-846.
12. Hollenberg M.D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15:1994;108-114.
13. Horowitz A., Menice C.B., Laporte R., Morgan K.G. Mechanisms of smooth muscle contraction. Physiol. Rev. 76:1996;967-1003.
14. Jais P., Weerasooriya R., Shah D.C., Hocini M., Macle L., Choi K.J., Scavee C., Haissaguerre M., Clementry J. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc. Res. 54(2):2002;337-346. (May).
15. Janssen L.J., Lu-Chao H., Netherton S. Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am. J. Physiol. 280:2001;L666-L674.
16. Jin N., Siddiqui R.A., English D., Rhoades R.A. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am. J. Physiol. 271:1996;H1348-H1358.
17. Kato M., Staub N.C. Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ. Res. 19:1966;426-440.
18. Kemp B.K., Smolich J.J., Cocks T.M. Evidence for specific regional patterns of response to different vasoconstrictors and vasodilators in sheep isolated pulmonary arteries and veins. Br. J. Pharmacol. 121:1997;441-450.
19. Laniyonu A.A., Saifeddine M., Ahmad S., Hollenberg M.D. Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br. J. Pharmacol. 113:1994;403-410.
20. Laniyonu A.A., Saifeddine M., Yang S.G., Hollenberg M.D. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can. J. Physiol. Pharm. 72:1994;1075-1085.
21. 2+ sensitivity of vascular smooth muscle contraction. Life Sci. 68:2000;363-372.
22. Michelakis E.D., Weir K., Wu X., Nsair A., Waite R., Hasimoto K., Puttagunta L., Knaus H.G., Archer S.L. Potassium channels regulate tone in rat pulmonary vein. Am. J. Physiol. 280:2001;L1138-L1147.
23. Miller D.S., Yaghi A., Hamilton J.T., Paterson N.A. Role of arachidonic acid metabolites in hypoxic contractions of isolated porcine pulmonary artery and vein. Exp. Lung Res. 15:1989;213-222.
24. Nagasaka Y., Bhattacharya J., Nanjo S., Gropper M.A., Staub N.C. Micropuncture measurements of lung microvascular pressure profile during hypoxia in cats. Circ. Res. 54:1984;90-95.
25. Paes de Almeida O., Bahm C., De Paula Carvalho M., Paes de Carvalho A. The cardiac muscle in pulmonary vein of the rat: morphological and electrophysiological study. J. Morphol. 145:1975;409-433.
26. Paillart C., Carlier E., Guedin D., Dargent B., Couraud F. Direct block of voltage-sensitive sodium channels by genistein, tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 280:1997;521-526.
27. Raj J.U., Chen P. Microvascular pressures measured by micropuncture in isolated perfused lamb lung. J. Appl. Physiol. 61:1986;2194-2201.
28. Raj J.U., Chen P. Micropuncture measurement of microvascular pressures isolated lamb lung during hypoxia. Circ. Res. 59:1986;398-404.
29. Semenchuk L.A., Di Salvo J. Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett. 370:1995;127-130.
30. Tsuda T., Kawahara Y., Shii K., Koide M., Ishida Y., Yokoyama M. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 285:1991;44-48.
31. Uzun O., Demiryurek A.T., Kanzik I. The role of tyrosine kinase in hypoxic constriction of sheep pulmonary artery rings. Eur. J. Pharmacol. 358:1998;41-47.
32. Uzun O., Demiryurek A.T., Kanzik I. The role of Gs proteins in hypoxic constriction of sheep pulmonary artery rings. Pharmacology. 64:2002;214-216.
33. Voelkel N.F., Czartolomna J. Vanadate potentiates hypoxic pulmonary vasoconstriction. J. Pharmacol. Exp. Ther. 259:1991;666-672.
34. Wijetunge S., Aalkjaer C., Schachter M., Hughes A.D. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189:1992;1620-1623.
35. Zhao Y., Packer C.S., Rhoades R.A. Pulmonary vein contracts in response to hypoxia. Am. J. Physiol. 265:1993;L87-L92.
36. Zhao Y., Packer C.S., Rhoades R.A. The vein utilizes different sources of energy than the artery during pulmonary hypoxic vasoconstriction. Exp. Lung Res. 22:1996;51-63.
37. Zhao Y., Rhoades R.A., Packer C.S. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. Am. J. Physiol. 271:1996;L768-L774.